CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SIMPATHIC focuses on accelerating drug repurposing for rare neurological, neurometabolic, and neuromuscular disorders. By developing standardized procedures and innovative clinical trial designs, the project aims to provide broader access to effective therapies for patients with overlapping symptoms and genetic backgro…
Drug repurposing can fill an important gap for rare disease patient groups with large unmet medical needs.
In comparison to traditional drug development, drug repurposing reduces the time and costs for drug development, regulatory approval, and market authorization.
Yet, we need to increase the efficiency of the drug repurposing pathway to provide broader access to new therapeutic modalities for larger groups of patients. SIMPATHIC’s main objective is to accelerate drug repurposing for rare neur…
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Greece, Agia Paraskevi
Type: Research institute
Activity type: Research Organisations
SME: No
Slovenia, Ljubljana
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
